We use cookies for a better user experience. Read our Privacy Policy

I Agree

Sexually Transmitted Disease Testing Market

Sexually Transmitted Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2031

Global Sexually Transmitted Disease Testing market: Overview

The occurrence of sexually transmitted diseases has increased as a result of a rise in unprotected sex, driving growth of the global sexually transmitted disease testing market. Even if a person does not have symptoms but has had unprotected intercourse, doctors will typically recommend STD testing. Viral load monitoring, genotyping, molecular diagnostics, and immunoassays are some of the STD diagnostics available in the market.

During the COVID-19 outbreak, screening rates for infections like gonorrhea and chlamydia decreased, but weekly positive rates climbed, as per the Quest Diagnostics 2020 Health Trends, presented by researchers from Penn State University in 2021. Even during initial months of the Covid-19 outbreak, the researchers discovered that testing as well as screening for sexually transmitted illnesses had reduced by 63 % for males and 59 % for women. The researchers also discovered that STI testing declined by as much as 40% from late February to early April 2020. As a result of the decline in testing owing to lockdowns as well as absence of access to testing facilities, the STD diagnostics business can suffer. Globally rising STD occurrence, increasing patient awareness via educational efforts, and expanding government projects are expected to fuel expansion of the global sexually transmitted disease testing market.

Disease type, location of testing, and region are important factors in the market that has been considered for the classification of the global sexually transmitted disease testing market.

Global Sexually Transmitted Disease Testing market: Notable Developments

The New York State Department of Health approved the utilization of Enzo Biochem's Chlamydia (CT/NG) nucleic acid amplification molecular tests and AmpiProbe gonorrhoeae in July 2019.

Some of the major players in the global sexually transmitted disease testing market are as mentioned below

  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • MedMira Inc.
  • Diasorin S.p.A
  • Cepheid (Danaher Corporation)
  • Hologic, Inc.

Global Sexually Transmitted Disease Testing Market: Key Trends

Below-mentioned developments, restraints, opportunities, and drivers are anticipated to characterize the global sexually transmitted disease testing market

High Prevalence of HIV in Low and Middle-income Countries to Support Market Expansion

HIV remains a significant public health concern across the world. As per WHO, most of the people who live with AIDS can be found in low- and middle-income countries, with 66 % of them residing in Sub-Saharan Africa in 2019. South Africa is responsible for a third of all new HIV infections in the region. The rate has risen dramatically, owing to greater diagnostic rates. In 2018, 7.52 million individuals were projected to be living with AIDS, as per GHE Charity's tbfacts.org website.

Molecular diagnostics, such as the nucleic acid amplification test (NAAT), are utilized to diagnose a variety of STDs, including chlamydia. It is a molecular test that identifies DNA, Chlamydia trachomatis' genetic information. The procedure is typically more specific and sensitive than previous chlamydia tests, and it can be conducted on a vaginal swab retrieved from women, obviating the need for a pelvic exam.

Molecular testing, direct DNA probes, or NAATs are also the most sensitive tests for T. vaginalis and are currently the gold standard for identifying these infections. Samples taken for testing of chlamydial and gonorrhea infections can also be utilized to screen for T. vaginalis using various nucleic acid amplification techniques. NAATs may usually be utilized with both urine and vaginal samples in women. Only a few have been authorized for utilization with samples obtained from males.

Global Sexually Transmitted Disease Testing Market: Geographical Analysis

Due to the higher incidence of STDs in the region, North America is likely to dominate the global sexually transmitted disease testing market. Due to the presence of a huge number of diagnostic firms and increasing disease awareness, the U.S. is likely to be one of the leading markets in the North America region. As per the United States Centers for Disease Control and Prevention, rates of gonorrhea, syphilis, and chlamydia have risen for 5 years in a row in the US, and are now at epidemic levels, with more than 2.55 million incidences of diagnosed STDs in 2019. 

Sexually Transmitted Disease Testing Market

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes


Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.


Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved